Skip to main content
Home
Search
Multi-scale Atlas
NEW
Search for Drug ADMET Endpoint Profile (DAE)
NEW
Search for Drug Pharmacogenomic Perturbation Map (DPP)
NEW
Search for Drug-Molecule Activity Atlas (DMA)
NEW
Drug Development Portfolio
Search for Drug
Search for Combinatorial Drug (CBD)
Search for Repurposed Drug (RPD)
Drug-interacting Molecule
Search for Drug Therapeutic Target (DTT)
Search for Drug Transporter (DTP)
Search for Drug-Metabolizing Enzyme (DME)
Search for Drug Off-target (DOT)
Disease
Search for Disease
Download
Help
About
Details of the Drug Formulaction
General Information of Drug Formulation (ID: F10992)
Formulation Name
Labetalol 200 mg tablet
Company
NCS HealthCare of KY, Inc dba Vangard Labs
Pharmaceutical Drug(s) in Formulation
Drug Name
Drug ID
Indication
ICD 11
Status
Labetalol
DMK8U72
Hypertension
BA00-BA04
Approved
--------------------
Pharmaceutical Excipient(s) in Formulation
Excipient Name
Excipient ID
PubChem CID
Functional Classification
Lactose monohydrate
E00393
104938
Binding agent; Diluent; Dry powder inhaler carrier; Lyophilization aid
Magnesium stearate
E00208
11177
lubricant
Polysorbate 80
E00665
Not Available
Dispersing agent; Emollient; Emulsifying agent; Plasticizing agent; Solubilizing agent; Surfactant; Suspending agent
Titanium dioxide
E00322
26042
Coating agent; Colorant; Opacifying agent
--------------------